Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Januvia-Pancreatic Cancer Lawsuit Investigation Announced by New York Attorney

July 30, 2013

Januvia, a popular diabetes drug, has been linked to Pancreatic and Thyroid Cancer. A prominent New York Attorney has announced his firm is investigating Januvia-Pancreatic Cancer Lawsuits.

Commack, NY (PRWEB) July 30, 2013

Januvia and Janumet have recently raised concerns about their possible connection to Pancreatic and Thyroid Cancer, both major and vicious diseases *1. Rudolph Migliore, a premier New York Attorney, has directed his firm to investigate Januvia-related Pancreatic and Thyroid Cancer lawsuits. The firm currently has active investigations into suspected Januvia related diseases and encourages more plaintifs to come forward so that their claims for compensation can be reviewed. The firm recently launched DiabetesDrugProblems.com to provide more information to the public and give resources to those who may have suffered major complications at the hands of Januvia or Janumet. Rudolph F.X. Migliore, P.C. provides free consultations nationwide to those who may have suffered from Januvia or Janumet.

Attorney Rudolph Migliore states, "Pancreatic Cancer is a horrific disease with great suffering and a high mortality rate. Surely, anything of this nature should have had the most stringent and extensive research and care by the pharmaceutical companies before they even considered putting it on the market."

In March 2013, the Food and Drug Administration announced that it would be reviewing the data from studies relating to Incretin Mimetics and Pancreatic Cancer findings. Januvia and Janumet are in the class of Incretin Mimetics *2. The FDA is currently investigating these reports and encourages those experiencing adverse events from these drugs to contact the FDA medwatch program. Several Januvia Lawsuits are currently filed and were just recently presented before the Judicial Panel on Multidistrict Litigation *3. This panel will determine if the lawsuits should be consolidated.

If you, a loved one, or someone you know has developed Pancreatic or Thyroid Cancer after taking Januvia or Janumet, please contact Rudolph F.X. Migliore, P.C. for a free case evaluation. The firm works with nationally recognized associated firms to obtain major verdicts and settlements on behalf of their clients. Please call Rudolph Migliore at (888) – 980 – 7396 or visit DiabetesDrugProblems.com

*1 Lawyers and Settlements, July 16, 2013- lawyersandsettlements.com/articles/januvia-side-effects/januvia-lawsuit-side-effects-cancer-3-18900.html?utm_expid=3607522

2.QRdCdW42SWGLZa0nRc6K3w.0#.UfV01r-Lpbw

*2 Food and Drug Administration, March 14, 2013- fda.gov/Drugs/DrugSafety/ucm343187.htm

*3 The Judicial Panel on Multi-district Litigation, July 25, 2013- jpml.uscourts.gov/sites/jpml/files/Hearing_Order-7-25-13.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10972182.htm


Source: prweb